Stocks Traded Mixed amid Vaccine Study Updates, Earnings

U.S. stocks traded mixed on Monday morning as investors braced for a barrage of quarterly results from corporations and developments on coronavirus vaccine candidates. The Dow Jones Industrial Average lately fell 66.21 points, or 0.25%, to 26,605.74. The S&P 500 was up 7.32 points, or 0.23%, to 3,232.05. The Nasdaq Composite gained 111.62 points, or 1.06%, to 10,614.81.

Oil futures traded lower Monday as global cases of coronavirus exceeded 14.5 million, raising worries that economies around the world. West Texas Intermediate crude for August delivery was off 54 cents, or 1.3%, at $40.05 a barrel. September Brent crude declined by 74 cents, or 1.7%, at $42.40 a barrel.

The Lancet medical journal published promising results of a Covid-19 vaccine study by the University of Oxford and AstraZenaca. Pfizer and BioNTech reported positive early data from their own Covid-19 vaccine study.